AMETEK INC/ AME
AMETEK, Inc. ("AMETEK" or the "Company") is incorporated in Delaware. Its predecessor was originally incorporated in Delaware in 1930 under the name American Machine and Metals, Inc. AMETEK is a leading global manufacturer of electronic instruments and electromechanical devices with operations in North America, Europe, Asia and South America. AMETEK maintains its principal executive offices at 1100 Cassatt Road, Berwyn, Pennsylvania, 19312. Listed on the New York Stock Exchange (symbol: AME), the common stock of AMETEK is a component of the Standard and Poor's 500 and the Russell 1000 Indices.
AMETEK's products are marketed and sold worldwide through two operating groups: Electronic Instruments ("EIG") and Electromechanical ("EMG"). Electronic Instruments is a leader in the design and manufacture of advanced instruments for the process, power and industrial, and aerospace markets. Electromechanical is a differentiated supplier of precision motion control solutions, highly engineered medical components and devices, thermal management systems, specialty metals and electrical interconnects. Its end markets include aerospace and defense, medical, automation and other industrial markets.
Valuation FY2025 figures against the last close
Where the revenue comes from as reported in the latest 10-K
Revenue by segment
- EIG
- EMG
| Segment | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| EIG | $4.92B | $4.66B | $4.62B |
| EMG | $2.48B | $2.28B | $1.97B |
As the company reported it, from the “Reportable Segments and Geographic Areas Information - Reportable Segment Financial Information (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Segments are the filer's own reporting structure, which is a decision about how it runs itself rather than a standard taxonomy: two companies in the same industry routinely divide themselves along different lines, so these are worth reading down a single company rather than across two. Slices under 1% are folded into “Other”.
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.40B | $6.94B | $6.60B | $6.15B | $5.55B | $4.54B | $5.16B | $4.85B | $4.30B | $3.84B |
| Cost of revenue | $4.73B | $4.46B | $4.21B | $4.01B | $3.63B | $3.00B | $3.37B | $3.19B | $2.86B | $2.59B |
| Gross profit | $2.67B | $2.48B | $2.38B | $2.15B | $1.91B | $1.54B | $1.79B | $1.66B | $1.44B | $1.25B |
| R&D | $236.1M | $236.6M | $220.8M | $198.8M | $194.2M | $158.9M | $161.9M | $141.0M | $130.4M | $112.0M |
| SG&A | $757.1M | $696.9M | $677.0M | $644.6M | $603.9M | $515.6M | $610.3M | $584.0M | $535.2M | $463.6M |
| Total operating expenses | $5.49B | $5.16B | $4.89B | $4.65B | $4.24B | $3.51B | $3.98B | $3.77B | $3.40B | $3.05B |
| Operating income | $1.91B | $1.78B | $1.71B | $1.50B | $1.31B | $1.03B | $1.18B | $1.08B | $903.6M | $791.0M |
| Interest expense | $81.3M | $113.0M | $81.8M | $83.2M | $80.4M | $86.1M | $88.5M | $82.2M | $98.0M | $94.3M |
| Pre-tax income | $1.80B | $1.66B | $1.61B | $1.43B | $1.22B | $1.08B | $1.07B | $987.7M | $796.7M | $693.1M |
| Income tax | $318.2M | $285.4M | $293.2M | $269.1M | $233.1M | $209.9M | $208.5M | $209.8M | $115.3M | $180.9M |
| Net income | $1.48B | $1.38B | $1.31B | $1.16B | $990.1M | $872.4M | $861.3M | $777.9M | $681.5M | $512.2M |
| EPS, basic | 6.42 | 5.95 | 5.70 | 5.04 | 4.29 | 3.80 | 3.78 | 3.37 | 2.96 | 2.20 |
| EPS, diluted | 6.40 | 5.93 | 5.67 | 5.01 | 4.25 | 3.77 | 3.75 | 3.34 | 2.94 | 2.19 |
| Shares, diluted (wtd. avg.) | 231.3M | 232.2M | 231.5M | 231.5M | 232.8M | 231.2M | 229.4M | 232.7M | 231.8M | 233.7M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $458.0M | $374.0M | $409.8M | $345.4M | $346.8M | $1.21B | $393.0M | $354.0M | $646.3M | $717.3M |
| Receivables | $1.12B | $948.8M | $1.01B | $919.3M | $829.2M | $597.5M | $744.8M | $732.8M | $668.2M | $592.3M |
| Inventory | $1.11B | $1.02B | $1.13B | $1.04B | $769.2M | $559.2M | $624.6M | $624.7M | $540.5M | $492.1M |
| Total current assets | $3.02B | $2.60B | $2.82B | $2.53B | $2.13B | $2.52B | $2.03B | $1.84B | $1.93B | $1.93B |
| Property, plant and equipment | $855.2M | $818.6M | $891.3M | $635.6M | $617.1M | $526.5M | $548.9M | $554.1M | $493.3M | $473.2M |
| Goodwill | $7.17B | $6.56B | $6.45B | $5.37B | $5.24B | $4.22B | $4.05B | $3.61B | $3.12B | $2.82B |
| Other intangibles | $4.13B | $3.92B | $4.17B | $3.34B | $3.37B | $2.62B | $2.76B | $2.40B | $2.01B | $1.73B |
| Total assets | $16.07B | $14.63B | $15.02B | $12.43B | $11.90B | $10.36B | $9.84B | $8.66B | $7.80B | $7.10B |
| Accounts payable | $618.0M | $523.3M | $516.6M | $497.1M | $470.3M | $360.4M | $377.2M | $399.6M | $437.3M | $369.5M |
| Short-term debt | $1.21B | $654.3M | $1.42B | $226.1M | $315.1M | $132.3M | $497.4M | $358.9M | $308.1M | $278.9M |
| Total current liabilities | $2.84B | $2.10B | $2.88B | $1.56B | $1.56B | $1.08B | $1.43B | $1.26B | $1.14B | $924.4M |
| Long-term debt | $1.07B | $1.43B | $1.90B | $2.16B | $2.23B | $2.28B | $2.27B | $2.27B | $1.87B | $2.06B |
| Total liabilities | $5.44B | $4.98B | $6.29B | $4.95B | $5.03B | $4.41B | $4.73B | $4.42B | $3.77B | $3.84B |
| Retained earnings | $12.25B | $11.06B | $9.94B | $8.86B | $7.90B | $7.09B | $6.39B | $5.65B | $5.00B | $4.40B |
| Total equity | $10.63B | $9.66B | $8.73B | $7.48B | $6.87B | $5.95B | $5.12B | $4.24B | $4.03B | $3.26B |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.80B | $1.83B | $1.74B | $1.15B | $1.16B | $1.28B | $1.11B | $925.5M | $833.3M | $756.8M |
| Depreciation and amortisation | $145.5M | $135.3M | $122.5M | $113.7M | $108.5M | $101.3M | $101.4M | $85.4M | $82.0M | $74.8M |
| Stock-based compensation | $47.8M | $47.9M | $46.2M | $47.4M | $46.1M | $41.6M | $40.4M | $27.3M | $25.1M | $22.0M |
| Capital expenditure | $130.2M | $127.1M | $136.2M | $139.0M | $110.7M | $74.2M | $102.3M | $82.1M | $75.1M | $63.3M |
| Investing cash flow | -$1.06B | -$244.8M | -$2.38B | -$552.8M | -$2.06B | $61.6M | -$1.15B | -$1.21B | -$625.8M | -$452.4M |
| Financing cash flow | -$686.3M | -$1.60B | $697.3M | -$575.7M | $39.3M | -$539.4M | $72.9M | $13.0M | -$329.2M | $57.1M |
| Dividends paid | $285.3M | $258.8M | $230.3M | $202.2M | $184.6M | $165.0M | $127.5M | $128.9M | $82.7M | $83.3M |
| Buybacks | $434.0M | $212.0M | $7.8M | $332.8M | $14.7M | $4.7M | $11.9M | $367.7M | $6.9M | $336.1M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001037868-26-000016.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.84B | $4.30B | $4.85B | $5.16B | $4.54B | $5.55B | $6.15B | $6.60B | $6.94B | $7.40B |
| Gross profit | $1.25B | $1.44B | $1.66B | $1.79B | $1.54B | $1.91B | $2.15B | $2.38B | $2.48B | $2.67B |
| Net income | $512.2M | $681.5M | $777.9M | $861.3M | $872.4M | $990.1M | $1.16B | $1.31B | $1.38B | $1.48B |
Recent filings and events
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Other event Item 8.01
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
- Other event Item 8.01
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Other event Item 8.01
- Results announced Item 2.02
- Other event Item 8.01
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 3823
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| DHR | DANAHER CORP /DE/ | $162.04B | 45.6x | 2.9% |
| KEYS | Keysight Technologies, Inc. | $53.59B | 64.1x | 8.0% |
| ROP | ROPER TECHNOLOGIES INC | $43.33B | 30.9x | 12.3% |
| FTV | Fortive Corp | $18.37B | 34.8x | 1.9% |
| MKSI | MKS INC | $13.29B | 45.0x | 9.6% |
| CGNX | COGNEX CORP | $9.34B | 81.7x | 8.7% |
| RAL | Ralliant Corp | $7.36B | — | -4.0% |
| ST | Sensata Technologies Holding plc | $5.88B | 192.3x | -5.8% |